Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 9 | 2018 | 44 | 1.320 |
Why?
|
| Neutrophils | 4 | 2014 | 102 | 0.850 |
Why?
|
| Phospholipids | 2 | 2014 | 27 | 0.770 |
Why?
|
| Multigene Family | 7 | 2017 | 47 | 0.690 |
Why?
|
| Eicosanoids | 2 | 2016 | 7 | 0.690 |
Why?
|
| gamma-Linolenic Acid | 2 | 2016 | 7 | 0.680 |
Why?
|
| Arachidonic Acid | 5 | 2015 | 35 | 0.630 |
Why?
|
| Lipids | 4 | 2015 | 211 | 0.620 |
Why?
|
| Fatty Acids | 2 | 2015 | 93 | 0.610 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2017 | 1079 | 0.580 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2017 | 29 | 0.520 |
Why?
|
| Fish Oils | 2 | 2014 | 34 | 0.520 |
Why?
|
| Inflammation | 4 | 2017 | 508 | 0.510 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 100 | 0.450 |
Why?
|
| DNA Methylation | 3 | 2018 | 130 | 0.410 |
Why?
|
| Dietary Supplements | 4 | 2017 | 170 | 0.400 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 26 | 0.390 |
Why?
|
| Diastole | 1 | 2011 | 91 | 0.390 |
Why?
|
| Memory | 1 | 2011 | 187 | 0.350 |
Why?
|
| Linoleic Acid | 4 | 2017 | 14 | 0.330 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2016 | 32 | 0.320 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2017 | 52 | 0.300 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 18 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1383 | 0.290 |
Why?
|
| European Continental Ancestry Group | 6 | 2018 | 1131 | 0.260 |
Why?
|
| Aging | 1 | 2011 | 881 | 0.250 |
Why?
|
| African Americans | 5 | 2017 | 1373 | 0.240 |
Why?
|
| Humans | 22 | 2018 | 29259 | 0.240 |
Why?
|
| Cholesterol | 3 | 2015 | 231 | 0.240 |
Why?
|
| Brain | 1 | 2011 | 930 | 0.240 |
Why?
|
| Animals | 9 | 2016 | 7317 | 0.210 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2014 | 4 | 0.200 |
Why?
|
| Chromatography, Thin Layer | 2 | 2014 | 8 | 0.200 |
Why?
|
| Phospholipase D | 2 | 2014 | 5 | 0.200 |
Why?
|
| Type C Phospholipases | 2 | 2014 | 9 | 0.200 |
Why?
|
| Middle Aged | 9 | 2018 | 10879 | 0.170 |
Why?
|
| Male | 10 | 2018 | 17883 | 0.160 |
Why?
|
| Saliva | 1 | 2018 | 36 | 0.160 |
Why?
|
| Leukocytes | 1 | 2018 | 52 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 47 | 0.160 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 3 | 2013 | 11 | 0.160 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 23 | 0.160 |
Why?
|
| Mutation | 3 | 2009 | 469 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 165 | 0.150 |
Why?
|
| Gene Frequency | 3 | 2012 | 225 | 0.150 |
Why?
|
| Aged | 6 | 2016 | 9520 | 0.140 |
Why?
|
| Stearic Acids | 1 | 2015 | 5 | 0.140 |
Why?
|
| Female | 10 | 2018 | 18256 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 20 | 0.140 |
Why?
|
| Diet | 2 | 2017 | 356 | 0.140 |
Why?
|
| Temporal Lobe | 1 | 2015 | 41 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 99 | 0.130 |
Why?
|
| Liver | 2 | 2015 | 464 | 0.130 |
Why?
|
| Adult | 7 | 2018 | 8471 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2013 | 26 | 0.130 |
Why?
|
| United States | 2 | 2015 | 3649 | 0.130 |
Why?
|
| Corn Oil | 1 | 2014 | 1 | 0.130 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 157 | 0.130 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 192 | 0.130 |
Why?
|
| Triglycerides | 1 | 2015 | 214 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2015 | 868 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 251 | 0.130 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2011 | 14 | 0.130 |
Why?
|
| Leukotrienes | 1 | 2013 | 4 | 0.120 |
Why?
|
| Echium | 1 | 2013 | 10 | 0.120 |
Why?
|
| Overweight | 1 | 2015 | 259 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2014 | 126 | 0.120 |
Why?
|
| Plant Oils | 1 | 2013 | 14 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 36 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 51 | 0.110 |
Why?
|
| Body Weight | 2 | 2011 | 290 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2011 | 9 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2011 | 10 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 9 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 27 | 0.100 |
Why?
|
| Siblings | 1 | 2011 | 24 | 0.100 |
Why?
|
| alpha-Linolenic Acid | 3 | 2017 | 11 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 441 | 0.100 |
Why?
|
| Encephalitis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Family Health | 1 | 2011 | 78 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 350 | 0.100 |
Why?
|
| Cell Count | 1 | 2011 | 51 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 148 | 0.100 |
Why?
|
| Vision, Ocular | 1 | 2011 | 30 | 0.100 |
Why?
|
| Risk Factors | 2 | 2015 | 3554 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 196 | 0.090 |
Why?
|
| Geography | 1 | 2010 | 34 | 0.090 |
Why?
|
| Genetics, Population | 1 | 2010 | 30 | 0.090 |
Why?
|
| Community Health Services | 1 | 2010 | 54 | 0.090 |
Why?
|
| Threonine | 1 | 2009 | 10 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2014 | 667 | 0.090 |
Why?
|
| Asthma | 1 | 2013 | 397 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 2010 | 90 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 108 | 0.090 |
Why?
|
| Hippocampus | 1 | 2011 | 185 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 520 | 0.090 |
Why?
|
| X Chromosome Inactivation | 1 | 2008 | 5 | 0.080 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2008 | 5 | 0.080 |
Why?
|
| Phosphatidylinositols | 1 | 2008 | 2 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2008 | 7 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 311 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 24 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 97 | 0.080 |
Why?
|
| Health Promotion | 1 | 2010 | 220 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 45 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2010 | 229 | 0.080 |
Why?
|
| Depression | 1 | 2011 | 383 | 0.080 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Cognition | 1 | 2011 | 526 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1607 | 0.070 |
Why?
|
| Alleles | 2 | 2018 | 251 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2018 | 24 | 0.070 |
Why?
|
| Models, Biological | 1 | 2007 | 373 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 1068 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 159 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 2413 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 981 | 0.040 |
Why?
|
| Protein Binding | 2 | 2009 | 199 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 77 | 0.040 |
Why?
|
| CpG Islands | 1 | 2017 | 44 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 104 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 139 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2017 | 68 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2015 | 26 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 735 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 3114 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 20 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 165 | 0.030 |
Why?
|
| Seeds | 1 | 2013 | 9 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 101 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 50 | 0.030 |
Why?
|
| Adolescent | 2 | 2013 | 3267 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2014 | 114 | 0.030 |
Why?
|
| Africa | 1 | 2012 | 23 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 467 | 0.030 |
Why?
|
| Complement C5 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Complement C7 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2011 | 3 | 0.030 |
Why?
|
| Complement C3 | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 23 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2013 | 801 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 107 | 0.020 |
Why?
|
| Protestantism | 1 | 2010 | 5 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2010 | 16 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 63 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 3 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 17 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 26 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 59 | 0.020 |
Why?
|
| Lung | 1 | 2011 | 233 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 37 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2011 | 389 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 226 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2011 | 264 | 0.020 |
Why?
|
| Cytochrome b Group | 1 | 2008 | 2 | 0.020 |
Why?
|
| Introns | 1 | 2008 | 39 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 6 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2008 | 13 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 30 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 25 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 73 | 0.020 |
Why?
|
| Liposomes | 1 | 2008 | 26 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 95 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 8 | 0.020 |
Why?
|
| Organelles | 1 | 2008 | 3 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 81 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 62 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 75 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 283 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 354 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 455 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1019 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 297 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 2380 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 2007 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2115 | 0.020 |
Why?
|